Cafepharma | Pharmaceutical Sales, Medical Sales, Lab Sales

Cafepharma Today

September 26 2023 - Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case

Gilead Sciences, after trial win, moves ahead with $247M settlement in HIV antitrust case
J&J, IBM face class-action lawsuit over patient data breach
Massive Kaiser Permanente strike looms as talks head to the wire
Alfasigma to acquire Intercept Pharma for $19 per share in cash
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

[video]Health Care Shocker Stock: Abbott

TheStreet.com

Friday, January 16, 2009 - 8:47am

tags:

Abbott Laboratories

The Promised Land for Generic Drugs

InVivo

Friday, January 16, 2009 - 8:40am

tags:

generics, Teva Pharmaceuticals, Barr Laboratories

Medical Devices Win U.S. Nod Without Proof of Safety

Bloomberg

Friday, January 16, 2009 - 8:38am

tags:

Warner Chilcott Files New Lawsuit for Infringement of DORYX(R) Patent

Yahoo

Friday, January 16, 2009 - 8:37am

tags:

Warner Chilcott, Sandoz, patents, DORYX

AstraZeneca Drug Raises Diabetes Risk, Doctor Says

Bloomberg

Friday, January 16, 2009 - 8:18am

tags:

AstraZeneca, diabetes, antipsychotics, Seroquel

J&J Sideswipes Boston Scientific

Forbes

Friday, January 16, 2009 - 8:08am

tags:

JNJ, Cordis, Boston Scientific, stents

Pfizer May Fire 2,400, One-Third of U.S. Sales Force

Bloomberg

Thursday, January 15, 2009 - 9:58pm

tags:

layoffs, Pfizer

Genentech reports financial results after the market closes as buyout shadow lingers

Yahoo/AP

Thursday, January 15, 2009 - 9:16am

tags:

Genentech, buyouts, earnings

Nycomed signs $59 million osteoporosis deal with EffRx

PharmaTimes, UK

Thursday, January 15, 2009 - 9:07am

tags:

Nycomed, osteoporosis, EffRx

What's Wrong with Pharma? One Answer from JP Morgan

InVivo

Thursday, January 15, 2009 - 9:03am

tags:

Trading FDA Decisions: Cypress Bioscience Soars, A Trio of Buys

Seeking Alpha

Thursday, January 15, 2009 - 9:01am

tags:

Cypress Bioscience, FDA, Schering Plough, Forest Labs, Savella, Saphris, Momenta, Amag Pharmaceuticals, BioDelivery Sciences

Investors Should Benefit from Johnson & Johnson in 2009

Seeking Alpha

Thursday, January 15, 2009 - 8:59am

tags:

Novartis’s Jimenez: Cafepharma Habitue

WSJ Online

Thursday, January 15, 2009 - 8:18am

tags:

Novartis, cafepharma, Joe Jimenez

Lilly to Plead Guilty and Pay $1.42 Billion in Zyprexa Probe

Bloomberg

Thursday, January 15, 2009 - 8:15am

tags:

Eli Lilly, Zyprexa

Wyeth's Prevnar Wipes Out Targeted Meningitis Germs While Others Flourish

Bloomberg

Thursday, January 15, 2009 - 8:13am

tags:

Wyeth, Prevnar, meningitis

Forest Laboratories and Cypress Bioscience say fibromyalgia drug gains FDA approval

Yahoo/AP

Thursday, January 15, 2009 - 8:11am

tags:

Forest Labs, Cypress Bioscience, fibromyalgia, Savella

Newer schizophrenia drugs cause heart risks: study

Reuters, UK

Wednesday, January 14, 2009 - 8:12pm

tags:

schizophrenia, Eli Lilly, Abilify, Zyprexa, Otsuka, Bristol-Myers Squibb

Biotech, Generics Will Lead Health Stocks in 2009

TheStreet.com

Wednesday, January 14, 2009 - 7:03pm

tags:

generics, biotech

Genentech expected to meet forecasts in quarter overshadowed by potential Roche buyout offer

Yahoo/AP

Wednesday, January 14, 2009 - 7:01pm

tags:

Genentech, Roche, earnings, buyouts

Lilly nears $1.4B Zyprexa agreement, report says

Yahoo/AP

Wednesday, January 14, 2009 - 6:59pm

tags:

Eli Lilly, Zyprexa

Pages

Latest CP Wire Articles

Eastman introduces new excipient to formulate poorly soluble API

Most-clicked pharma news for week ending April 1 2023: Signify Health acquisition, Ferring Research Institute shutdown, Jardiance sales increase, and more

PharmaBlock Receives 2023 ACS CMO Excellence in Green Chemistry Award

PharmaBlock Opens New R&D Facility in Pennsylvania ——Expanding Capacity to Deliver GMP Projects

Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy

Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases

Klick Health launches new healthcare venture studio

Medtech earnings reports: insights from major players' Q4 results

Key compliance issues for medtech firms transitioning to data-enabled solutions

Following FDA COVID vaccine advisory panel vote, Novavax is prepared to provide a revised vaccine

Latest Pharmagather Articles

Drug Channels News Roundup, September 2023: PBM Profits, Specialty Rx Markups, CVS Spending Trends, Pharmacy Pricing Secrets, and Deductibles 101

Drug Channels

EXCLUSIVE: The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021

Drug Channels

A Clear Path to Education Affordability Requires Meeting Patients Where They Are

Drug Channels

NEW: The Drug Channels 2024 Video Webinar Series

Drug Channels

Do Plan Sponsors Understand How Their PBMs Make Money?

Drug Channels

Informa Connect’s Patient Support Services Congress

Drug Channels

How Payers Are Reacting to Insulin Price Changes

Drug Channels

White Bagging Update 2023: Saving Money or Shifting Costs?

Drug Channels

Available for Preorder: The 2023-24 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

Drug Channels